NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it has licensed technology from ActivX Biosciences that it plans to use to develop new mass spectrometry analysis and sample enrichment tools.

The Activity-Based Protein Profiling (ABPP) technology that Thermo Fisher licensed can be used for accurate and broad activity-based profiling of several enzyme families in any biological samples, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.